Mark Rezak, Director, Compliance Consulting, joins the panel discussing important updates to FDA procedures and requirements that should be considered when preparing for inspections.
We Value Your Privacy
Please select the types of cookies you would like to accept. Necessary cookies cannot be disabled. Visit our Privacy Policy to learn more.